Condition 1: Inflammatory Tinea Capitis. Condition 2: Kerion.
Conditions
Interventions
Intervention 1: First Intervention group: This group receives Terbinafine plus placebo. Based on the patients weight, less than 25 kilograms 125 mg, between 25-45 kilograms 187.5 mg, and more than 45
Sponsors
Kermanshah University of Medical Sciences
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: All Patients with Inflammtory Tinea Capitis that have been confirmed Clinically and by Smear and Culture.
Exclusion criteria
Exclusion criteria: Patients who have Previosly recieved Corticosteroids Patients with Immune System Deficiency Pregnancy Breastfeding Diabetic patient
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Scar rate. Timepoint: Before treatment and four months after treatment. Method of measurement: photo.;????? ???? ?? ????? ?? ???????. Timepoint: Before treatment and 2 months after treatment. Method of measurement: Questionnaire: Based on the clinical symptoms of redness, edema, pustule, scaling, itching, pain and hair loss, it will be scored. Scoring will be done from a minimum score of 0 to a maximum score of 7. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSoheila Azmoodeh
Kermanshah University of Medical Sciences
Outcome results
None listed